Abstract | Context: Case Description: A man originally from North Africa was referred to the University of Pennsylvania Lipid Clinic for severe hypertriglyceridemia and recurrent pancreatitis, consistent with the clinical diagnosis of FCS. Molecular analyses of FCS-associated genes revealed a homozygous missense variant R72T in APOC2. Molecular modeling of the variant predicted that the apolipoprotein C-II R72T peptide has reduced lipid binding affinity. In vitro studies of the patient's plasma confirmed the lack of functional apoC-II activity. Moreover, the apoC-II protein was undetectable in the patient's plasma, quantitatively as well as qualitatively. Conclusions:
|
Authors | Masako Ueda, Richard L Dunbar, Anna Wolska, Tracey U Sikora, Maria Del Rosario Escobar, Naomi Seliktar, Emil deGoma, Stephanie DerOhannessian, Linda Morrell, Adam D McIntyre, Frances Burke, Denis Sviridov, Marcelo Amar, Robert D Shamburek, Lita Freeman, Robert A Hegele, Alan T Remaley, Daniel J Rader |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 102
Issue 5
Pg. 1454-1457
(05 01 2017)
ISSN: 1945-7197 [Electronic] United States |
PMID | 28201738
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2017 Endocrine Society |
Chemical References |
|
Topics |
- Adult
- Apolipoprotein C-II
(deficiency, genetics)
- Black People
- Homozygote
- Humans
- Hyperlipoproteinemia Type I
(complications, genetics, metabolism)
- Hypertriglyceridemia
(etiology, metabolism)
- Male
- Mutation, Missense
- Pancreatitis
(etiology, metabolism)
- Recurrence
|